AF
ACAD icon

Allworth Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

Allworth Financial’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.1K Buy
872
+459
+111% +$10.1K ﹤0.01% 3111
2026
Q1 		$9.19K Sell
413
-132
-24% -$3.15K ﹤0.01% 3567
2025
Q4 		$14.6K Sell
545
-44
-7% -$1.05K ﹤0.01% 3012
2025
Q3 		$12.6K Buy
589
+330
+127% +$7.8K ﹤0.01% 2997
2025
Q2 		$5.59K Buy
259
+39
+18% +$725 ﹤0.01% 3204
2025
Q1 		$3.26K Buy
220
+26
+13% +$472 ﹤0.01% 3002
2024
Q4 		$3.46K Buy
194
+165
+569% +$2.66K ﹤0.01% 2925
2024
Q3 		$447 Hold
29
– – ﹤0.01% 3443
2024
Q2 		$515 Sell
29
-62
-68% -$1K ﹤0.01% 3367
2024
Q1 		$1.68K Hold
91
– – ﹤0.01% 2875
2023
Q4 		$2.85K Hold
91
– – ﹤0.01% 2516
2023
Q3 		$1.9K Hold
91
– – ﹤0.01% 2566
2023
Q2 		$2.18K Hold
91
– – ﹤0.01% 2450
2023
Q1 		$1.71K Buy
+91
New +$1.73K ﹤0.01% 2467
2022
Q4 		– Sell
-820
Closed -$13K – 2984
2022
Q3 		$13K Buy
820
+729
+801% +$11.8K ﹤0.01% 1464
2022
Q2 		$1K Sell
91
-997
-92% -$18.6K ﹤0.01% 2064
2022
Q1 		$26K Buy
1,088
+13
+1% +$315 ﹤0.01% 1135
2021
Q4 		$25K Buy
1,075
+984
+1,081% +$19.8K ﹤0.01% 1025
2021
Q3 		$2K Hold
91
– – ﹤0.01% 1649
2021
Q2 		$2K Hold
91
– – ﹤0.01% 1348
2021
Q1 		$2K Sell
91
-121
-57% -$5.33K ﹤0.01% 1278
2020
Q4 		$11K Buy
+212
New +$10.5K ﹤0.01% 804

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Allworth Financial's ACAD Position: Q2 2026 in Review

Allworth Financial increased its Acadia Pharmaceuticals (ACAD) stake by 111% in Q2 2026, buying an estimated $10.1K and bringing the position to 872 shares worth $22.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3111.

Allworth Financial first reported a position in ACAD in Q4 2020 and has held it in 22 quarters since. The position peaked at $26K in Q1 2022. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Allworth Financial held 872 shares of Acadia Pharmaceuticals worth $22.1K as of Q2 2026.
  • Allworth Financial bought 459 Acadia Pharmaceuticals shares in Q2 2026, an estimated $10.1K.
  • Acadia Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3111 holding.
  • Allworth Financial first reported a position in Acadia Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Allworth Financial's Acadia Pharmaceuticals position peaked at $26K in Q1 2022.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.